IPAM
GSK icon

Investment Partners Asset Management’s GSK GSK Stock Holding History

Investment Partners Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,564
Closed -$252K – 175
2026
Q1 		$252K Sell
4,564
-7,485
-62% -$406K 0.16% 145
2025
Q4 		$591K Sell
12,049
-2,082
-15% -$97.1K 0.37% 77
2025
Q3 		$610K Buy
14,131
+335
+2% +$13.1K 0.4% 72
2025
Q2 		$530K Sell
13,796
-2,262
-14% -$86.4K 0.37% 81
2025
Q1 		$622K Sell
16,058
-744
-4% -$27.2K 0.49% 65
2024
Q4 		$568K Buy
16,802
+1,243
+8% +$44.7K 0.45% 68
2024
Q3 		$636K Buy
15,559
+344
+2% +$14.1K 0.52% 59
2024
Q2 		$586K Buy
15,215
+255
+2% +$10.7K 0.52% 58
2024
Q1 		$641K Hold
14,960
– – 0.58% 52
2023
Q4 		$554K Buy
+14,960
New +$537K 0.55% 58

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM

Investment Partners Asset Management's GSK Position: Q2 2026 in Review

Investment Partners Asset Management sold out of GSK (GSK) in Q2 2026, closing a stake of 4,564 shares — an estimated $252K sold.

Investment Partners Asset Management first reported a position in GSK in Q4 2023 and held it in 10 quarters. The position peaked at $641K in Q1 2024. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Investment Partners Asset Management reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Investment Partners Asset Management sold 4,564 GSK shares in Q2 2026, an estimated $252K.
  • Investment Partners Asset Management first reported a position in GSK in Q4 2023 and held it in 10 quarters.
  • Investment Partners Asset Management's GSK position peaked at $641K in Q1 2024.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Investment Partners Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.